News Powered By:
– a collaborative partner.
CenterWatch : December 12, 2017 8:18 am : Centerwatch, CROs/Service Providers, Global News, Microsoft, Parexel, Technology Solutions
PAREXEL International, a global biopharmaceutical services organization, introduced the Perceptive Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp. Perceptive Cloud elevates PAREXEL Informatics solutions into an enhanced cloud infrastructure built on Microsoft Azure, combining PAREXEL’s extensive industry expertise and innovative technology solutions with the power of Microsoft’s […]
CenterWatch : December 12, 2017 7:30 am : Awards & Advancement, Centerwatch, CluePoints, Global News
CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen its business development team. Nick Borders and Rob Estrella join the CluePoints U.S. team to support its impressive global business growth, allowing the company to increase its expanding client base across North […]
CenterWatch : December 11, 2017 2:53 pm : Awards & Advancement, Centerwatch, Certara, Global News
Certara, a global leader in model-informed drug development and regulatory science, announced that Leigh Farrell, PhD, Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). The presentation will take place today at the Australasian […]
The post Certara introduces New Investigator Awards program in Australia appeared first on CenterWatch News Online.
CenterWatch : December 11, 2017 2:52 pm : Centerwatch, Clinical Intelligence, COMPASS Pathways, Global News, Worldwide Clinical Trials
COMPASS Pathways, a healthcare company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it is partnering with Worldwide Clinical Trials to conduct a major program of late-stage clinical trials for psilocybin therapy for treatment-resistant depression. Depression is the leading cause of ill-health and disability worldwide, and one of the fastest growing health […]
CenterWatch : December 11, 2017 2:50 pm : Boehringer Ingelheim, Centerwatch, Distributed Bio, Global News, R&D Trends
Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce an agreement with Boehringer Ingelheim to license the Distributed Bio SuperHuman Platform for accelerating biotherapeutics discovery across therapeutic areas. “The SuperHuman Platform represents the culmination of a decade of our research in computational library design,” says Jacob […]
The post Distributed Bio, Boehringer Ingelheim announce SuperHuman Platform Transfer appeared first on CenterWatch News Online.